Regarding staining status of ezrin, the HBV-HCC patients with positive ezrin immunoreactivity had smaller tumor size, higher frequency of cirrhosis, tumor de-differentiation, satellite lesions, and vascular invasion. Here, EZR is linked to hepatocellular carcinoma.